Associate ProfessorAukland District Health Board / Auckland Hospital, New Zealand
Disclosure information not submitted.
Multimodal Imageable Eye90 microspheres® Radioembolization for Hepatocellular Carcinoma - 6 Month Interim Safety and Efficacy and 3 Month Liver Volume Results from a First in Human Trial
Monday, March 25, 20243:45 PM – 3:54 PM MT